3-aminobenzamide has been researched along with Leucocythaemia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Pogrebniak, A | 1 |
Schemainda, I | 1 |
Pelka-Fleischer, R | 1 |
Nüssler, V | 1 |
Hasmann, M | 1 |
Yamadori, I | 1 |
Yoshino, T | 1 |
Kondo, E | 1 |
Cao, L | 1 |
Akagi, T | 1 |
Matsuo, Y | 1 |
Minowada, J | 1 |
Tentori, L | 1 |
Turriziani, M | 1 |
Franco, D | 1 |
Serafino, A | 1 |
Levati, L | 1 |
Roy, R | 1 |
Bonmassar, E | 1 |
Graziani, G | 1 |
3 other studies available for 3-aminobenzamide and Leucocythaemia
Article | Year |
---|---|
Poly ADP-ribose polymerase (PARP) inhibitors transiently protect leukemia cells from alkylating agent induced cell death by three different effects.
Topics: 1-Naphthylamine; Adenosine Triphosphate; Alkylating Agents; Apoptosis; Benzamides; Cell Death; Cell | 2003 |
Comparison of two methods of staining apoptotic cells of leukemia cell lines. Terminal deoxynucleotidyl transferase and DNA polymerase I reactions.
Topics: Antibodies, Monoclonal; Apoptosis; Benzamides; Cell Nucleus; Coloring Agents; Cytoplasm; Deoxyribonu | 1998 |
Treatment with temozolomide and poly(ADP-ribose) polymerase inhibitors induces early apoptosis and increases base excision repair gene transcripts in leukemic cells resistant to triazene compounds.
Topics: Antineoplastic Agents, Alkylating; Apoptosis; Benzamides; Dacarbazine; DNA Glycosylases; DNA Ligases | 1999 |